Title: Type III Interferons in Hepatitis C Virus Infection
Passage: in patients chronically infected with HCV . However, this was not confirmed in two other independent studies in Japanese or Italian cohorts . Finally, HCV-related liver disease is a multifactorial problem, and the independent association of genetic factors may not be a clear cut. Fortunately, with the development of highly effective DAAs, it is expected that these complications will be less frequent as SVR will be achievable in most patients. Type III IFNs in HCV Infection Frontiers in Immunology | www.frontiersin.org December 2016 | Volume 7 | Article 628